Related Experiment Video
Updated: Aug 5, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Future Trends in Cancer Prevention and Interception in Cancer Predisposition Syndromes: Leveraging Insights From
Yiming Wang1,2,3,4, David Malkin2,3,4,5, Steven M Lipkin6
1Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.
International Journal of Cancer
|August 1, 2026
Summary
Genomic advances are revolutionizing cancer predisposition syndromes (CPS) management. Early diagnosis, surveillance, and novel prevention strategies offer a new era of precision cancer care for at-risk individuals.
Area of Science:
- Genomics
- Oncology
- Preventive Medicine
Background:
- Cancer predisposition syndromes (CPS) are significant causes of pediatric and adult cancers.
- Germline pathogenic variants in cancer predisposition genes (CPGs) underlie these syndromes.
- Genomic advancements are transforming the diagnosis and management of CPS.
Purpose of the Study:
- To review recent advances in the diagnosis, surveillance, and management of CPS.
- To highlight the role of genomic technologies in improving cancer prevention and interception.
- To discuss emerging strategies for precision cancer prevention in individuals with CPS.
Main Methods:
- Comprehensive germline and tumor-normal sequencing for diagnostic precision.
- Integration of genome and long-read sequencing for variant detection.
- Review of evidence-based surveillance protocols and novel minimally invasive tools like liquid biopsies.
- Evaluation of emerging medical and immunoprevention strategies.
Main Results:
- Genomic sequencing enhances early identification of at-risk individuals, irrespective of family history.
- Newborn screening strategies (e.g., TP53 R337H) show clinical utility and cost-effectiveness.
- Surveillance protocols improve early tumor detection and survival rates.
- Emerging strategies like metformin, aspirin, and neoantigen vaccines show promise for cancer risk modification and interception.
Conclusions:
- Advances in genomic technologies and novel therapeutic strategies represent a paradigm shift in CPS management.
- These innovations offer a framework for precision cancer prevention and interception of pre-malignant lesions.
- Continued research, collaboration, and health economic evaluations are crucial for clinical translation.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...